Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lisa V E Oostenbrink"'
Autor:
M. Y. Eileen C. van der Stoep, Lisa V. E. Oostenbrink, Robbert G. M. Bredius, Dirk Jan A. R. Moes, Henk-Jan Guchelaar, Juliette Zwaveling, Arjan C. Lankester
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Allogeneic hematopoietic stem cell transplantation (HSCT) is an established curative treatment that has significantly improved clinical outcome of pediatric patients with malignant and non-malignant disorders. This is partly because of the use of saf
Externí odkaz:
https://doaj.org/article/aab977d8e9ee488c9aa14ced7a54e661
Autor:
Chantal Kroone, Chris Tieken, Begüm Kocatürk, Madelon Paauwe, Erik J. Blok, Betül Ünlü, Yascha W. van den Berg, Eliana Stanganello, Maaike Y. Kapteijn, Nathalie Swier, Xi Zhang, Danique E. M. Duits, Yazhi Lin, Lisa V. E. Oostenbrink, Rob F. P. van den Akker, Laurent O. Mosnier, Lukas J. Hawinkels, Bart J. M. van Vlijmen, Wolfram Ruf, Peter J. Kuppen, Suzanne C. Cannegieter, Jeroen T. Buijs, Henri H. Versteeg
Publikováno v:
Blood Advances. 7:2388-2400
Cancer enhances the risk of venous thromboembolism, but a hypercoagulant microenvironment also promotes cancer progression. Although anticoagulants have been suggested as a potential anticancer treatment, clinical studies on the effect of such modali
Autor:
Lisa V. E. Oostenbrink, Cornelia M. Jol-van der Zijde, Katrine Kielsen, Anja M. Jansen-Hoogendijk, Marianne Ifversen, Klaus G. Müller, Arjan C. Lankester, Astrid G. S. van Halteren, Robbert G. M. Bredius, Marco W. Schilham, Maarten J. D. van Tol
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Anti-thymocyte globulin (ATG) is a lymphocyte depleting agent applied in hematopoietic stem cell transplantation (HSCT) to prevent rejection and Graft-vs.-Host Disease (GvHD). In this study, we compared two rabbit ATG products, ATG-Genzyme (ATG-GENZ)
Externí odkaz:
https://doaj.org/article/8044e135e7df45b3a36d392be8be61d7
Autor:
Anja M. Jansen-Hoogendijk, Astrid G. S. van Halteren, Robbert G. M. Bredius, Maarten J. D. van Tol, Alexander B. Mohseny, Lisa V E Oostenbrink, Emma S. Pool, Arjan C. Lankester, Cornelia M. Jol-van der Zijde, Frans J. Smiers, Carly Vervat, Marco W. Schilham
Publikováno v:
Bone Marrow Transplantation. SPRINGERNATURE
Bone Marrow Transplantation
Bone Marrow Transplantation
The use of HLA-mismatched (un)related donors is historically associated with a higher incidence of transplant-related complications and mortality. However, the use of such donors may overcome the limited availability of HLA-matched donors for patient
Autor:
Maarten J. D. van Tol, Anja M. Jansen-Hoogendijk, Cornelia M. Jol-van der Zijde, Robbert G. M. Bredius, Astrid G. S. van Halteren, Emma S. Pool, Dirk Jan A.R. Moes, Alex B. Mohseny, Lisa V E Oostenbrink, Marco W. Schilham, Arjan C. Lankester, Frans J. Smiers
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 13, Iss 2, Pp 61-65 (2020)
Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG
Autor:
Astrid G. S. van Halteren, Arjan C. Lankester, Marianne Ifversen, Lisa V E Oostenbrink, Robbert G. M. Bredius, Cornelia M. Jol-van der Zijde, Erik G J von Asmuth, Marco W. Schilham, Maarten J. D. van Tol, Anja M. Jansen-Hoogendijk, Klaus Müller, Katrine Kielsen, Carsten Heilmann, Monique M. van Ostaijen-ten Dam
Publikováno v:
Journal of Immunology, 206(12), 2828-2838. AMER ASSOC IMMUNOLOGISTS
Differentially and functionally distinct T cell subsets are involved in the development of complications after allogeneic hematopoietic stem cell transplantation (HSCT), but little is known about factors regulating their recovery after HSCT. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17915f30c6f1c1c4c11e850ad35b8d1
https://hdl.handle.net/1887/3264386
https://hdl.handle.net/1887/3264386
Autor:
Lisa V E, Oostenbrink, Emma S, Pool, Cornelia M, Jol-van der Zijde, Anja M, Jansen-Hoogendijk, Carly, Vervat, Astrid G S, van Halteren, Robbert G M, Bredius, Frans J W, Smiers, Maarten J D, van Tol, Marco W, Schilham, Arjan C, Lankester, Alexander B, Mohseny
Publikováno v:
Bone marrow transplantation. 56(9)
The use of HLA-mismatched (un)related donors is historically associated with a higher incidence of transplant-related complications and mortality. However, the use of such donors may overcome the limited availability of HLA-matched donors for patient